Investigating the implementation of differentiated HIV services and implications for pregnant and postpartum women: A mixed methods multi-country study.
ART delivery
HIV
HIV policy implementation
differentiated service delivery
sub-Saharan Africa
Journal
Global public health
ISSN: 1744-1706
Titre abrégé: Glob Public Health
Pays: England
ID NLM: 101256323
Informations de publication
Date de publication:
02 2021
02 2021
Historique:
pubmed:
30
7
2020
medline:
3
11
2021
entrez:
30
7
2020
Statut:
ppublish
Résumé
Universal antiretroviral therapy (ART) for pregnant and postpartum women in sub-Saharan Africa has required adaptations to service delivery. We compared national policies on differentiated HIV service delivery with facility-level implementation, and explored provider and user experiences in rural Malawi, Tanzania and South Africa. Four national policies and two World Health Organization guidelines on HIV treatment for pregnant and postpartum women published between 2013 and 2017 were reviewed and summarised. Results were compared with implementation data from surveys undertaken in 34 health facilities. Eighty-seven in-depth interviews were conducted with pregnant and post-partum women living with HIV, their partners and providers. In 2018, differentiated service policies varied across countries. None specifically accounted for pregnant or postpartum women. Malawian policies endorsed facility-based multi-month scripting for clinically-stable adult ART patients, excluding pregnant or breastfeeding women. In Tanzania and South Africa, national policies proposed community-based and facility-based approaches, for which pregnant women were not eligible. Interview data suggested some implementation of differentiated services for pregnant and postpartum women beyond stipulated policies in all settings. Although these adaptations were appreciated by pregnant and postpartum women, they could lead to frustrations among other users when criteria for fast-track services or multi-month prescriptions were not clear.
Identifiants
pubmed: 32726177
doi: 10.1080/17441692.2020.1795221
pmc: PMC7612752
mid: EMS145041
doi:
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
274-287Subventions
Organisme : Medical Research Council
ID : MR/P014313/1
Pays : United Kingdom
Références
Swiss Med Wkly. 2017 Jul 11;147:w14485
pubmed: 28695551
Trop Med Int Health. 2015 Apr;20(4):430-47
pubmed: 25583302
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):21636
pubmed: 28770593
BMC Health Serv Res. 2017 Nov 21;17(1):758
pubmed: 29162065
J Int AIDS Soc. 2017 Jan 12;20(1):21188
pubmed: 28364566
Trop Med Int Health. 2015 Oct;20(10):1265-70
pubmed: 25962952
J Acquir Immune Defic Syndr. 2011 Feb 1;56(2):e39-44
pubmed: 21084990
BMC Health Serv Res. 2019 Feb 4;19(1):95
pubmed: 30717715
Hum Resour Health. 2014 May 02;12:24
pubmed: 24885454
J Int AIDS Soc. 2017 Jul 21;20(Suppl 4):22024
pubmed: 28770588
PLoS One. 2014 Mar 20;9(3):e91544
pubmed: 24651523
J Public Health Policy. 2012;33 Suppl 1:S23-34
pubmed: 23254846
Curr HIV/AIDS Rep. 2016 Oct;13(5):241-55
pubmed: 27475643
J Assoc Nurses AIDS Care. 2019 Sep-Oct;30(5):511-520
pubmed: 30720561
J Int AIDS Soc. 2018 Jan;21(1):
pubmed: 29356376
J Int AIDS Soc. 2018 Nov;21(11):e25207
pubmed: 30450699
Curr Opin HIV AIDS. 2019 Jan;14(1):60-65
pubmed: 30394947
J Int AIDS Soc. 2018 Sep;21(9):e25183
pubmed: 30225946
Front Pharmacol. 2017 Nov 09;8:751
pubmed: 29163151
PLoS One. 2018 Jan 19;13(1):e0191294
pubmed: 29351338
J Int AIDS Soc. 2016 Dec 01;19(1):21484
pubmed: 27914186
J Acquir Immune Defic Syndr. 2010 Dec;55(4):483-90
pubmed: 20683336
Bull World Health Organ. 2019 Mar 01;97(3):200-212
pubmed: 30992633
BMC Public Health. 2015 Feb 27;15:195
pubmed: 25884639